| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
183,462 |
169,918 |
$17.72M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
94,011 |
86,548 |
$16.08M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
40,745 |
37,367 |
$6.98M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
72,190 |
67,796 |
$5.23M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
48,787 |
44,139 |
$3.77M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
47,930 |
43,063 |
$3.13M |
| 71045 |
Radiologic examination, chest; single view |
60,742 |
55,543 |
$3.11M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,876 |
2,596 |
$1.50M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54,131 |
48,773 |
$1.43M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
3,503 |
1,998 |
$1.14M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
190,385 |
163,603 |
$1.01M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,980 |
21,468 |
$747K |
| 71046 |
Radiologic examination, chest; 2 views |
11,599 |
10,716 |
$655K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
11,039 |
10,059 |
$654K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,210 |
3,817 |
$651K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,132 |
997 |
$608K |
| J3490 |
Unclassified drugs |
156,259 |
84,724 |
$605K |
| 80053 |
Comprehensive metabolic panel |
79,996 |
65,914 |
$556K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16,598 |
15,160 |
$513K |
| G0378 |
Hospital observation service, per hour |
5,188 |
2,045 |
$491K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14,606 |
13,252 |
$460K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14,614 |
13,253 |
$460K |
| 36415 |
Collection of venous blood by venipuncture |
217,478 |
186,193 |
$458K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
67,761 |
61,883 |
$404K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,202 |
1,041 |
$403K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
159,561 |
97,589 |
$395K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
18,562 |
16,387 |
$391K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,659 |
6,038 |
$354K |
| 84703 |
|
53,992 |
49,206 |
$343K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,291 |
2,436 |
$307K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,379 |
7,742 |
$263K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,398 |
2,947 |
$258K |
| 87631 |
|
2,091 |
1,915 |
$252K |
| 83880 |
|
10,230 |
9,182 |
$214K |
| 81001 |
|
77,527 |
70,665 |
$186K |
| 87581 |
|
5,805 |
5,295 |
$183K |
| 87486 |
|
5,793 |
5,293 |
$182K |
| 80050 |
General health panel |
5,032 |
3,183 |
$174K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
32,981 |
29,905 |
$165K |
| 84484 |
|
22,794 |
18,825 |
$164K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,609 |
1,812 |
$161K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,476 |
7,642 |
$157K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,285 |
2,877 |
$151K |
| 83690 |
|
30,055 |
27,224 |
$150K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,903 |
2,434 |
$143K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
6,449 |
6,040 |
$142K |
| 80061 |
Lipid panel |
10,007 |
9,099 |
$109K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
281 |
227 |
$108K |
| 86780 |
|
8,298 |
7,834 |
$105K |
| 80076 |
|
18,320 |
16,722 |
$102K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
6,794 |
5,896 |
$100K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
216 |
188 |
$92K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
347 |
313 |
$92K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
621 |
451 |
$90K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21,783 |
18,251 |
$87K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,587 |
10,468 |
$81K |
| 76830 |
Ultrasound, transvaginal |
435 |
407 |
$72K |
| 99218 |
|
1,238 |
846 |
$71K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
810 |
554 |
$67K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,905 |
8,006 |
$66K |
| 97602 |
|
3,554 |
2,358 |
$66K |
| 83735 |
|
16,281 |
12,922 |
$58K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17,104 |
14,595 |
$58K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,003 |
2,745 |
$56K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
947 |
770 |
$56K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
205 |
180 |
$45K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,017 |
1,855 |
$40K |
| 76775 |
|
221 |
198 |
$39K |
| 86803 |
|
2,757 |
2,609 |
$38K |
| 87340 |
|
3,732 |
3,522 |
$37K |
| 86762 |
|
2,556 |
2,408 |
$35K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,801 |
685 |
$34K |
| 87390 |
|
1,568 |
1,527 |
$33K |
| C1776 |
Joint device (implantable) |
14 |
13 |
$32K |
| J9271 |
Injection, pembrolizumab, 1 mg |
22 |
13 |
$32K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,475 |
2,252 |
$30K |
| 84439 |
|
3,980 |
3,496 |
$29K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,880 |
3,910 |
$27K |
| 92557 |
|
415 |
374 |
$26K |
| 86738 |
|
2,052 |
1,938 |
$25K |
| 86003 |
|
806 |
375 |
$22K |
| 86300 |
|
1,603 |
1,128 |
$22K |
| 87150 |
|
680 |
639 |
$22K |
| 96417 |
|
259 |
174 |
$22K |
| 86850 |
|
3,743 |
3,481 |
$22K |
| 87070 |
|
3,333 |
3,002 |
$22K |
| 83655 |
|
1,747 |
1,674 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,556 |
1,467 |
$19K |
| 81003 |
|
10,048 |
8,960 |
$18K |
| 86702 |
|
1,566 |
1,526 |
$17K |
| 84481 |
|
1,797 |
1,521 |
$16K |
| 80069 |
|
5,892 |
3,764 |
$15K |
| 86701 |
|
1,569 |
1,528 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
143 |
129 |
$14K |
| 84681 |
|
46 |
13 |
$14K |
| 86787 |
|
1,053 |
996 |
$12K |
| J1453 |
Injection, fosaprepitant, 1 mg |
78 |
54 |
$12K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
222 |
217 |
$11K |
| 80197 |
|
4,213 |
2,416 |
$11K |
| 87081 |
|
1,376 |
1,305 |
$9K |
| 86901 |
|
3,237 |
3,010 |
$9K |
| 86900 |
|
3,239 |
3,012 |
$9K |
| 82784 |
|
1,046 |
968 |
$8K |
| 59025 |
Fetal non-stress test |
321 |
198 |
$8K |
| 72100 |
|
156 |
140 |
$8K |
| 83516 |
|
697 |
521 |
$8K |
| 83605 |
|
1,058 |
857 |
$8K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
14 |
$7K |
| 80074 |
|
237 |
213 |
$7K |
| 96367 |
|
402 |
183 |
$7K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
560 |
444 |
$7K |
| 83021 |
|
357 |
347 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,062 |
992 |
$7K |
| 86140 |
|
1,564 |
1,364 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,241 |
963 |
$6K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
16 |
13 |
$6K |
| 97161 |
|
143 |
108 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
841 |
535 |
$6K |
| 84702 |
|
485 |
427 |
$6K |
| 85027 |
|
3,559 |
2,401 |
$6K |
| 99223 |
Prolong inpt eval add15 m |
609 |
312 |
$6K |
| 82607 |
|
492 |
463 |
$6K |
| 82950 |
|
1,217 |
1,168 |
$5K |
| 74019 |
|
110 |
102 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$5K |
| 67311 |
|
19 |
12 |
$5K |
| 51798 |
|
237 |
228 |
$5K |
| 93296 |
|
548 |
526 |
$5K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
198 |
180 |
$5K |
| 83020 |
|
357 |
347 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
8,217 |
6,304 |
$4K |
| 86364 |
|
834 |
538 |
$4K |
| 82746 |
|
406 |
378 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
30 |
29 |
$4K |
| 74022 |
|
81 |
73 |
$4K |
| 70210 |
|
44 |
41 |
$4K |
| 74018 |
|
51 |
49 |
$4K |
| 85610 |
|
1,546 |
1,338 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
873 |
715 |
$4K |
| 85730 |
|
993 |
882 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,562 |
5,414 |
$4K |
| 82962 |
|
1,538 |
1,330 |
$4K |
| 73130 |
|
43 |
40 |
$4K |
| 97162 |
|
74 |
65 |
$4K |
| 83993 |
|
244 |
230 |
$3K |
| 70355 |
|
234 |
206 |
$3K |
| 82550 |
|
731 |
646 |
$3K |
| 85652 |
|
1,465 |
1,315 |
$3K |
| 85379 |
|
429 |
390 |
$3K |
| 73560 |
|
26 |
24 |
$3K |
| 96415 |
|
56 |
40 |
$3K |
| 81002 |
|
772 |
688 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
562 |
462 |
$2K |
| 85660 |
|
478 |
448 |
$2K |
| 80164 |
|
295 |
261 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
222 |
217 |
$2K |
| 82785 |
|
161 |
139 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
151 |
137 |
$2K |
| 82150 |
|
421 |
388 |
$2K |
| 72040 |
|
46 |
41 |
$2K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
721 |
624 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,678 |
3,033 |
$2K |
| 86696 |
|
104 |
92 |
$2K |
| 72110 |
|
14 |
12 |
$2K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
61 |
57 |
$2K |
| 84436 |
|
351 |
306 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
75 |
40 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
285 |
257 |
$2K |
| 77336 |
|
27 |
12 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
14 |
13 |
$1K |
| 87077 |
|
555 |
412 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
237 |
220 |
$1K |
| 82728 |
|
155 |
138 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
257 |
227 |
$1K |
| 86695 |
|
104 |
92 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
54 |
24 |
$1K |
| 94644 |
|
14 |
13 |
$1K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
15 |
12 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
28 |
25 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
246 |
226 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
908 |
831 |
$988.53 |
| 87040 |
|
139 |
86 |
$972.46 |
| J7510 |
Prednisolone oral, per 5 mg |
433 |
388 |
$969.59 |
| 83550 |
|
154 |
135 |
$952.31 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
27 |
12 |
$938.64 |
| 84146 |
|
51 |
48 |
$928.52 |
| 83540 |
|
198 |
177 |
$908.25 |
| 86480 |
|
18 |
17 |
$867.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,203 |
838 |
$791.36 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
994 |
666 |
$767.93 |
| J9045 |
Injection, carboplatin, 50 mg |
15 |
12 |
$696.32 |
| 86255 |
|
57 |
55 |
$642.51 |
| 87186 |
|
279 |
216 |
$641.72 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
28 |
24 |
$631.29 |
| 82570 |
|
143 |
127 |
$591.85 |
| 81222 |
|
35 |
27 |
$557.61 |
| 86008 |
|
37 |
28 |
$554.08 |
| 84100 |
|
167 |
145 |
$552.43 |
| 17250 |
|
16 |
12 |
$524.88 |
| 87799 |
|
214 |
172 |
$505.75 |
| 87497 |
|
54 |
49 |
$457.54 |
| 96523 |
|
16 |
13 |
$433.68 |
| 83630 |
|
26 |
25 |
$423.60 |
| 84156 |
|
142 |
127 |
$415.66 |
| 29581 |
|
46 |
13 |
$369.66 |
| 85045 |
|
110 |
73 |
$359.58 |
| 86376 |
|
34 |
29 |
$349.20 |
| 81511 |
|
389 |
334 |
$338.87 |
| 86038 |
|
45 |
35 |
$338.52 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,101 |
939 |
$317.49 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
50 |
26 |
$312.64 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
15 |
12 |
$262.57 |
| J1790 |
Injection, droperidol, up to 5 mg |
42 |
39 |
$260.89 |
| 86308 |
|
51 |
49 |
$257.73 |
| 86215 |
|
19 |
17 |
$252.50 |
| 86304 |
|
17 |
12 |
$249.72 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14,513 |
9,171 |
$241.33 |
| 82247 |
|
52 |
27 |
$237.16 |
| 83527 |
|
18 |
16 |
$233.82 |
| 85014 |
|
89 |
89 |
$232.66 |
| 85018 |
|
89 |
89 |
$232.66 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
4,198 |
2,117 |
$214.36 |
| 83525 |
|
18 |
16 |
$204.81 |
| 86039 |
|
18 |
16 |
$199.68 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
426 |
336 |
$191.47 |
| 87328 |
|
13 |
13 |
$179.66 |
| 82657 |
|
225 |
172 |
$179.48 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
13 |
12 |
$176.63 |
| 80299 |
|
13 |
13 |
$176.20 |
| 82105 |
|
17 |
15 |
$166.90 |
| 87329 |
|
13 |
13 |
$155.74 |
| 80183 |
|
16 |
12 |
$145.75 |
| J0697 |
Injection, sterile cefuroxime sodium, per 750 mg |
3,523 |
1,996 |
$140.57 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
15 |
14 |
$140.56 |
| 86060 |
|
19 |
17 |
$139.10 |
| 95249 |
|
13 |
12 |
$138.19 |
| 86706 |
|
12 |
12 |
$128.88 |
| 87102 |
|
12 |
12 |
$94.29 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
19 |
13 |
$94.14 |
| C9113 |
Injection, pantoprazole sodium, per vial |
16 |
15 |
$84.42 |
| 83615 |
|
22 |
13 |
$79.88 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
14 |
13 |
$71.51 |
| 82248 |
|
15 |
15 |
$65.66 |
| 82947 |
|
24 |
16 |
$65.01 |
| 87206 |
|
12 |
12 |
$60.44 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
44 |
27 |
$55.01 |
| 84550 |
|
12 |
12 |
$54.24 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
12 |
$47.15 |
| 87209 |
|
15 |
12 |
$43.44 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
47 |
39 |
$35.95 |
| 87177 |
|
15 |
12 |
$18.50 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
135 |
118 |
$12.71 |
| J7799 |
Noc drugs, other than inhalation drugs, administered through dme |
180 |
135 |
$11.80 |
| 81015 |
|
39 |
37 |
$3.05 |
| 0352U |
|
87 |
69 |
$0.00 |